AEOI Spokesman Behrouz Kamalvandi said on Tuesday that the Atomic Energy Organization has offered considerable assistance to the healthcare sector in recent years. He noted that the AEOI has signed a contract with the Food and Drug Administration of the Health Ministry to produce 66 new radiopharmaceuticals.
A series of homegrown radiopharmaceuticals for the diagnosis and treatment of cancer are developed with world-class quality, he added.
In December 2022, the AEOI chief said Iran aims to become a global hub for manufacturing deuterium drugs.
“In a not too distant future we will turn into a hub for manufacturing drugs based on deuterium which are good alternatives to chemical drugs and have lower side effects in comparison (to those drugs),” he stated.
The AEOI launched a second phase of its deuterium production unit in Arak Heavy Water Reactor Facility in central Iran in April 2021.
Iran achieves ‘unparalleled naval power’, acquires remote warfare capabilities
